Abstract
Interest in sudden unexpected and unexplained death in individuals with epilepsy (SUDEP) was rekindled in the United States by Jay and Leestma during the early 1980s and more recently by antiepileptic drug (AED) trials and medicolegal issues. The incidence of SUDEP has been and is being evaluated in North America and the United Kingdom. Specific criteria for the classification of definite, probable, possible, and unlikely SUDEP implemented in United States epidemiologic studies are presented. Evidence for the increased relative risk for sudden death in epilepsy compared with the general population is also discussed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
